Abstract
Alterations to cilia are responsible for a wide range of severe disease; however, understanding of the transcriptional control of ciliogenesis remains incomplete. In this study we investigated whether altered cilia-mediated signaling contributes to the pleiotropic phenotypes caused by the Forkhead transcription factor FOXC1. Here, we show that patients with FOXC1-attributable Axenfeld–Rieger Syndrome (ARS) have a prevalence of ciliopathy-associated phenotypes comparable to syndromic ciliopathies. We demonstrate that altering the level of Foxc1 protein, via shRNA mediated inhibition, CRISPR/Cas9 mutagenesis and overexpression, modifies cilia length in vitro. These structural changes were associated with substantially perturbed cilia-dependent signaling [Hedgehog (Hh) and PDGFRα], and altered ciliary compartmentalization of the Hh pathway transcription factor, Gli2. Consistent with these data, in primary cultures of murine embryonic meninges, cilia length was significantly reduced in heterozygous and homozygous Foxc1 mutants compared to controls. Meningeal expression of the core Hh signaling components Gli1, Gli3 and Sufu was dysregulated, with comparable dysregulation of Pdgfrα signaling evident from significantly altered Pdgfrα and phosphorylated Pdgfrα expression. On the basis of these clinical and experimental findings, we propose a model that altered cilia-mediated signaling contributes to some FOXC1-induced phenotypes.
| Original language | English |
|---|---|
| Article number | 20278 |
| Journal | Scientific Reports |
| Volume | 14 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 2024 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024.
Funding
We are grateful to the patients who participated in this study. We thank Drs. Sudipto Roy (National University of Singapore), Michael Walter (University of Alberta), Peter Carlsson (University of Gothenburg), and Valerie Wallace (University of Toronto) for critically reviewing earlier versions of the manuscript. Funding was provided by the Canadian Institutes of Health Research (CIHR) (MOP-133658) and Women and Children's Health Research Institute (to OJL), Natural Sciences and Engineering Research Council (to AJW and FBB) and Alberta Innovates Health Solutions (to IMM). This study was funded by Alberta Innovates—Health Solutions, National Sciences and Engineering Research Council of Canada (No. NSERC RGPIN-2016-04682), Canadian Institutes of Health Research (No. MOP-133658), Women and Children’s Health Research Institute (No. 3149).
| Funders | Funder number |
|---|---|
| National University Hospital, Singapore | |
| Toronto Western Hospital University of Toronto | |
| Alberta Innovates - Health Solutions | |
| Alberta Innovates Bio Solutions | |
| University of Alberta | |
| Valerie Wallace | |
| Canadian Institutes of Health Research | MOP-133658 |
| Natural Sciences and Engineering Research Council of Canada | RGPIN-2016-04682 |
| Women and Children's Health Research Institute | 3149 |
Keywords
- Axenfeld–Rieger syndrome
- FOXC1
- Hedgehog
- PDGFRα signaling
- Primary cilia
ASJC Scopus subject areas
- General